YSR-734

N/A

Report date: 2023/12/12 13:39:54
NME

Base Information

Drug NameYSR-734
Drug Alias NameYSR-734YSR734
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsMuscular Dystrophy, DuchenneLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Toronto MississaugaUniversity Of Toronto, Toronto
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Toronto, TorontoUniversity of Toronto Mississauga
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, DuchenneLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A